Shilpa Medicare Limited — Updates, 18-08-2026: General Updates
18-08-2026 | 04:10 pm
18-08-2026 | 04:10 pm
Shilpa Medicare voluntarily recalled ~27,900 vials of a chemotherapy drug in the US due to discoloration. This Class II recall is not expected to materially impact the company's financial position or operations.
No comments yet. Be the first to comment!
